Haemato-oncology / Acute Myeloid Leukaemia / Molecular Acrobatics. @gsttnhs @kingsmedicine
SE1 9RT
Joined January 2019
- Tweets94
- Following1.3K
- Followers1.3K
- Likes35
Richard Dillon retweeted
Read the review by Brunangelo Falini and @DillonHaem.
Criteria for diagnosis and molecular monitoring of #NPM1-mutated #AML.
bit.ly/3QSHni9
@UniperugiaNews @kingsmedicine #acutemyeloidleukemia #leusm
Dream Job Opportunity ! Academic Clinical Fellowship in Haematology (Guy's, King's, UCLH and Barts available) please contact me if interested in the Guy's / Kings one. oriel.nhs.uk/Web/PermaLink/V…
Richard Dillon retweeted
Congratulations to our REBEL alliance @WillVilliers, @BoriMifsud, @DillonHaem, @halimabensmail, @AbduElbasir and our non-Twittered colleagues for an excellent collaboration.
Congratulations to @WillVilliers on his first born paper, i'm sure its the first of many.
Well done to @WillVilliers and everyone involved for our new machine learning/multi-omics paper in @NatureComms.
nature.com/articles/s41467-0…
👇Here’s a recap:
Richard Dillon retweeted
Off to do some filming about what we can do RIGHT NOW to bring forward the day when no one dies of their blood cancer. @KingsCollegeLon & @GSTTnhs the location which is very apt given the vital role they both play in cancer discovery and treatment.
Richard Dillon retweeted
Have turned @DillonHaem’s office into a green room while he’s away - nice view Richard! Miss you!
Ultra sensitive detection of FLT3-ITD: a novel and powerful MRD marker - and one that could potentially be used to guide molecularly targeted interventions. Read all about it here!
ashpublications.org/blood/ar…
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia - Further results from the UK NCRI AML17 trial in collaboration with Australian colleagues. Hope you enjoy :-) sciencedirect.com/science/ar…
Richard Dillon retweeted
First patient recruited into Victor study @CV_UHB @DillonHaem @Tap_Clin_Trials , fantastic support again from the study team 👍👍
Richard Dillon retweeted
We would like to thank all the speakers who joined us for a serie of seminars : @tobiasmenne2 @AKienesberger @MosheMittelman @manosnikolousis @DrAmitPatel @DillonHaem - All recordings are now available here: acuteleuk.org/upcoming-semin…
Richard Dillon retweeted
Had to wait for a long train ride to fully listen to this truly unmissable interview
One great quote, among many:
“The biggest tragedy is not that our drugs don’t work very well - though that’s a tragedy. The biggest tragedy is that we don’t know who they’re gonna work in.”
Don't miss episode 4.02!
We interview Dr. George Sledge, professor at Stanford University Medical Center, former president of ASCO, on how and why he chose medicine and oncology, how his career grew, and how breast cancer treatment evolved. Tune in now!
soundcloud.com/plenarysessio…
Richard Dillon retweeted
RECOVERY Pre-print:
In patients hospitalised with COVID-19 but no natural antibody response, monoclonal antibody infusion:
- reduced mortality
- increased speed of discharge
- reduced progression to invasive mechanical ventilation or death
medrxiv.org/content/10.1101/…
Richard Dillon retweeted
Because our supporters were determined to keep donating & fundraising through the pandemic we were able to fund £2m of new research last month including @DillonHaem's team investigating if #AML can be treated without chemotherapy.
#amazing
👇 bloodcancer.org.uk/research/…
Richard Dillon retweeted
🚨 New research (part 1) 🚨
Reducing the need for chemotherapy in people with acute myeloid leukaemia (AML)
👨🔬 In this project @DillonHaem at @kingsmedicine will look for markers in DNA that will tell clinicians if people with AML are likely respond to a drug called venetoclax
Richard Dillon retweeted
Hayley joined @CCH_Bham at the height of the #COVID19 pandemic and has been working on vital #ClinicalTrials, including OCTAVE, which aims to evaluate how the body reacts to COVID19, following vaccination, in clinically vulnerable groups (thread)
#nursesday2021
Richard Dillon retweeted
VICTOR will enable patients to access an alternative, less intensive treatment for #AML. We hope this exciting study can reduce side effects vs. standard chemotherapy and even enable treatment at home (thread) #WorldAMLDay @KNOW_AML @CureLeukaemia @DillonHaem
Richard Dillon retweeted
Here are some completed @KNOW_AML word searches ✍🏻 how are you getting on?? Can you beat the time of 14 mins?! #KnowAML 🔴⚫️ #WorldAMLDay #AML – at Louth, England
Wow this is just amazing work
1/
We've just confirmed the effectiveness of the Pfizer-BioNTech vaccine outside of randomized trials.
Details @NEJM: nejm.org/doi/full/10.1056/NE…
Yes, great news, but let's talk about methodological issues that arise when using #observational data to estimate vaccine effectiveness.
